The effect of vamifeport and hepcidin on ferroportin degradation was evaluated, for the first time in vitro, in a human breast cancer cell line (T47D); expressing ferroportin, T47D cells were incubated with iron sulfate characterized by the stable isotope 58Fe [13]. The gene discussed is SLC40A1; the disease is breast cancer.